This company seems to have been delisted
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Albireo Pharma
ALBO
40,67 €
Share price
0.00%
Change (1 day)
119.76%
Change (1 year)
Categories
Albireo Pharma (ALBO) - Total assets
Total assets on the balance sheet as of September 2022 : €0.29 Billion
According to Albireo Pharma's latest financial reports the company's total assets are €0.29 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Albireo Pharma - Total assets on balance sheet (from 2005 to 2022)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2021-12-31 | €0.26 B | 14.86% |
| 2020-12-31 | €0.23 B | 57.58% |
| 2019-12-31 | €0.14 B | -9.11% |
| 2018-12-31 | €0.16 B | 165.65% |
| 2017-12-31 | €61.02 M | 29.26% |
| 2016-12-31 | €47.21 M | |
| 2016-09-30 | €25.73 M | -30.08% |
| 2015-09-30 | €36.8 M | 83.7% |
| 2014-09-30 | €20.03 M | -34.3% |
| 2013-09-30 | €30.49 M | -4.68% |
| 2012-09-30 | €31.99 M | 4.72% |
| 2011-09-30 | €30.55 M | 27.65% |
| 2010-09-30 | €23.93 M | -41.18% |
| 2009-09-30 | €40.68 M | -41.18% |
| 2008-09-30 | €69.17 M | 18.59% |
| 2007-09-30 | €58.33 M | 295.79% |
| 2006-09-30 | €14.73 M | 1383.42% |
| 2005-09-30 | €0.99 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 | €0.25 B | -14.66% | 🇺🇸 USA |